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Summary Survival rates for 67 women with bilateral breast cancer were compared to those for 1282 women
with unilateral disease in a follow-up of 1349 women participating in a population-based study. Relative
survival at 8 years of follow-up was 69% for women with unilateral disease as compared to 53% for women
with bilateral cancer. When possible confounding histopathological differences - data about which were
prospectively collected - and age were adjusted for in a multivariate analysis, the relative hazard rate was
significantly higher for women with bilateral versus unilateral breast cancer (P=0.006). The impact of interval
time between the two primaries was analysed and a roughly two-fold higher hazard rate was seen for
synchronous cancers with regularly falling risk for increasing interval times. This trend was however not
statistically significant. The results indicate that the two tumours contribute independently to the patient's
excess risk of dying and thus occur as two seemingly biologically unrelated events with respect to the tumour-
host relationship and metastatic behaviour.
The reported survival rates for women with bilateral breast
cancer as compared with women with unilateral cancer have
varied considerably. Both similar prognosis (Schell et al.,
1982; Slack et al., 1973; Nielsen et al., 1986; Mueller &
Ames, 1978) and a poorer prognosis (Robbins et al., 1964) in
bilateral cancer have been found. In some studies the results
of the comparisons varied, depending on whether the cancers
were synchronous or metachronous (McCredie et al., 1975;
Bailey et al., 1980; Burns et al., 1984; Turco et al., 1982).
However, the findings in several studies of these survival
rates are afflicted with uncertainty on account of selection of
the patient material, lack of control of confounding factors
and inadequate statistical methods.
We addressed these questions specifically in a long-term
follow-up of women participating in a population-based
case-control study which included nearly all incident cases of
breast cancer from one third of the Swedish population
diagnosed during a 14-month period (Adami et al., 1985).
The observed and relative survival were compared between
women with bilateral and those with unilateral breast cancer.
The influence of the time interval between diagnosis of the
two cancers was also analyzed. Confounding factors were
taken into account by multivariate techniques.
Materials and methods
Patients
All incident cases of breast cancer were registered contin-
uously during a 14-month period in 1977-78 for the purpose
of a case-control study (Adami et al., 1985). The study was
population-based and covered nearly one-third of the total
Swedish population.
During the study period 1,423 incident cases were regis-
tered. Within two months after diagnosis a questionnaire
was mailed to all patients in order to obtain information on
epidemiologic characteristics. Twenty-three women had died,
37 did not respond to the questionnaire and 14 gave
incomplete answers. Thus 1,349 cases (96%) were available
for further analysis.
A history of previously treated breast cancer was reported
by 67 of the 1,349 patients. This information was confirmed
by histopathologic (62), or cytologic reports (1) and medical
records (3) in a total of 66 women. One woman claimed to
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have been treated previously for breast cancer, but no
records were found to confirm or refute this statement. The
mean age at diagnosis in unilateral cases was 63.5 years and
in bilateral cases it was 55.2 and 65.2 at diagnosis of the first
and second primary cancer, respectively. The mean interval
between the diagnoses was thus 10 years and the median
interval was 7.5 years (range 0-37). Synchronous bilateral
cancer (diagnosed at the same hospital admission) occurred
in only one woman.
Treatment
The women were treated in several different hospitals in 11
counties and the treatment was accordingly not uniform.
However, total mastectomy was the only accepted routine
method for operable cases during this period of time. Owing
to regional differences in the treatment protocol, biopsy or
clearance of the axilla was not always performed, and a total
of 38 women were considered to be inoperable. The distribu-
tion of these two treatment variants did not differ between
unilateral and bilateral cancers: roughly 63% of the women
had an axillary clearance and 97% were deemed operable in
both groups. Routinely, postoperative irradiation was given
to women with stage II disease and/or when the resection
margins were invaded by tumour growth. During the period
of patient accrual, adjuvant systemic treatment was used
only at one hospital and exclusively for node-positive
patients.
Histopathologic evaluation
All available slides were re-examined blindly by one and the
same pathologist. The histologic classification according to
Ackerman et al. (1974) was used. The following characteris-
tics were coded according to standardized, predetermined
criteria and subsequently computerized: Histologic type (duc-
tal, lobular, papillary, colloid, medullary, tubular and ade-
noid cystic cancers); Ackerman classification; tumour grade;
cellular pleomorphism; presence of lympho-plasmocytic cel-
lular infiltrates in and around the cancer (graded as none,
slight, moderate or high). Histopathological tumour size and
multicentricity could not be reliably recorded, since the
pathologist had only access to the histopathological slides.
Vascular invasion is one of the separate measures classifying
a tumour into group IV according to Ackerman. When
information from the axilla was available, number of axillary
nodes with cancer involvement, presence of periglandular
metastatic growth, and sinus histiocytosis were recorded.
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Follow-up
A unique 10-digit national registration number (NRN) is
allocated to every Swedish citizen, and includes the date of
birth. In 1986, the NRN of every patient in the cohort was
checked and corrected if necessary. As a result, all women
could be followed up with respect to survival until June 1986
through computerized linkage to two national registers, viz.
the Causes of Death Register and a continuously updated
population register. By these combined means, all women
could be identified either as still alive at the end of the
observation period or as deceased. In the latter case, the date
of death was copied into the cohort data file. Survival was
the only end-point of interest. We therefore made no attempt
to carry out individual follow-up with respect to other
outcomes.
Analyses
The observed survival rates for all causes of death were
calculated by the actuarial (life-table) method, and the breast
cancer-specific mortality was determined by computing the
relative survival. The relative survival rates were calculated
as the ratio of the observed to the expected rates. The
expected survival rates were calculated from life tables
compiled according to 5-year age group, and 5-year calendar
period for the total female population of Sweden (Hakulinen
et al., 1985).
The annual conditional probability of death from breast
cancer was computed as the complement of annual relative
survival. The standard error of the observed survival rate
was computed from Greenwood's formula and the standard
error of the relative survival was computed as described by
Ederer et al. (1961). Ninety-five percent confidence limits
were used to estimate uncertainty in the calculated survival
rates.
Multivariate analyses
In order to compare the survival of women with bilateral
and unilateral cancer while taking into account other vari-
ables, the Cox proportional hazards model was used. The
basic model assumes that the hazard h(tlx) can be written
h(tlx)=hO(t)exp(fi1xj+ ...+fkxk), where ho(t) is a baseline
hazard function for individuals with all explanatory variables
X1,....,Xk equal to 0. The parameter f3i shows the change in
the logarithm of the hazard function as the variable xi
increases by one unit, given that the other variables are
unchanged. A positive value of fpi implies an increase in the
hazard function, i.e., poorer survival prospects. The effect on
the hazard associated with the variable xi is exp(fli).
(Lawless, 1982).
The effect of bilateral cancer was modelled in the following
two basic ways:
Cf)
Years
Figure 1 Observed survival for women with unilateral (0) and
bilateral (A) breast cancer. Observed survival at 8 years was
0.544 for unilateral and 0.409 for bilateral cancer. The difference
is not statistically significant.
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where D is an indicator variable taking the value 1 for a
bilateral cancer and 0 otherwise, while TIME is the time in
years between diagnosis of the first and second primary
cancer. Model B allows a non-linear effect of TIME. The
parameter 111 shows the relative hazard for synchronous
bilateral cancer.
Results
Overall and relative survival
Figure 1 shows the life table curves for observed survival
rates in the groups with bilateral and unilateral disease. The
relative survival curves are shown in Figure 2. There was no
statistically significant difference between the two groups for
either measure.
Years
Figure 2 Relative survival for women with unilateral (0) and
bilateral (A) breast cancer. 95% confidence intervals at 5- and 8-
year follow-up are given in the figure. Relative survival at 8
years was 0.694 for unilateral and 0.526 for bilateral cancer. The
difference is not statistically significant.
Multivariate analyses In the first set of multivariate models,
only age at diagnosis was taken into account as a possible
confounding factor (the unadjusted models in Table I). In
model 1, the prognosis for all women with bilateral cancer
was compared with that for women with unilateral disease.
Those with bilateral cancer were found to have a poorer
prognosis, but the difference did not reach the 5% level of
significance. In model 2 the interval between the first and
second primary cancer was taken into account. The same
was done in model 3, but here the influence of time was
(A)
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Table I Relative hazard rates with 95% confidence intervals in parentheses obtained in multi-
variate models taking age (unadjusted models) and age, histopathologic classification, and axillary
nodal status (adjusted models) into account as confounding factors. Comparison is made with the
prognosis in unilateral cases. Model 3 incorporates the time interval between the two primary
cancers with a logarithmic function. The value for synchronous cancer denotes the relative hazard
rate when the interval approaches 0
Total - no Synchronous Effect of time
correction for bilateral between first and
interval cancersa second primaryb
Model Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
1. Bilateral 1.4c 1.6d
cancer - total (0.99-1.9) (1.1-2.3)
2. Bilateral 1.7e 2.lf 0.98 0.98
cancer - interval (1.0-2.7) (1.3-3.3) (0.95-1.0) (0.94-1.0)
in years
3. Bilateral 2.1 2.69 0.82 0.80
cancer- interval (0.95-4.5) (1.2-5.6) (0.58-1.2) (0.56-1.1)
in ln(years+ 1)
aComputed as exp(/,3) in models A and B; bcomputed as exp(f12) in models A and B; cP=0.064;
dp=0.006; P=0.033; fP =0.003; gP =0.019.
analyzed under the assumption that the prognosis changed in
a logarithmic way. In both these models the hazard rate was
found to be highest for women with synchronous bilateral
disease and tended to decrease with a widening interval
between the two diagnoses. The trend was not statistically
significant, however (Table I).
The second set of multivariate models (the adjusted
models in Table I) was estimated by taking age, all histo-
pathologic characteristics of the mastectomy specimen, and
the axillary node status (when available) at the second breast
cancer into account as possible confounding factors. The
same pattern as in the first set of models appeared, but was
more pronounced. The overall increase in hazard rate asso-
ciated with a second breast cancer was now statistically
significant (Table I).
The effects of the time interval on the relative hazards
shown in Table I are presented in Table II for different
intervals (years). There was a consistent decrease in the
relative hazard over the years from a two-fold increase for
synchronous cancers to 1.5 and 1.0-1.2 on extrapolation to
10 and 30 years respectively. The findings were similar
whether time was incorporated in the model as a logarithmic
function or not. The trend is not statistically significant,
however.
Discussion
The women with bilateral breast cancer in this analysis were
drawn from a population-based study comprising nearly all
incident cases during a period of 14 months from one third
of the Swedish population. The recruitment time was thus
short and all diagnoses of the second breast cancer were
Table II Effects on the relative hazard of dying
after a diagnosis of bilateral breast cancer, as
compared with unilateral disease, with increasing
intervals. The model takes age, histopathologic
classification and axillary node status (when avail-
able) into account as confounding factors. In model
2 the interval is incorporated with a logarithmic
function/ln(time+ 1)/
1 2
Interval Time/linearl Time/ln(time+ 1)/
(years) relative hazard relative hazard
0 2.05 2.56
1 2.01 2.18
5 1.82 1.70
10 1.62 1.49
20 1.28 1.28
30 1.01 1.17
based on cytologic and/or histologic findings. The histopath-
ologic examinations were standardized. Tumour size was not
recorded, but there is no reason to believe that tumour size
for the second cancer in women with bilateral breast cancers
should be biased as compared to women with unilateral
disease. The differences in treatment were small and not of a
magnitude expected to introduce bias. The follow-up was
complete. Reliable background data were available for com-
puting the relative survival rate. The occurrence of bilateral
cancer was of the prevalence expected, but the total number
of 66 does not give high statistical power. In the analyses
possibly important confounding factors could be taken into
account by multivariate techniques.
The main finding in this study was that women with
bilateral breast cancer have a poorer prognosis than those
with unilateral disease. We found a relative hazard close to
two for synchronous cancer, with a regularly falling trend
for metachronous cancer with an increased interval between
diagnosis of the first and second tumour. Though not
statistically significant, this trend was consistent in different
multivariate models.
The Cox model assumes that the relative hazard associated
with a prognostic variable is the same irrespective of the
length of time after diagnosis. This is not necessarily true
and methods exist for relaxing this assumption. However,
the small number of observed bilateral cancers in our
material makes the statistical power of such analyses so low
that no attempt at estimation was made.
Our results are consistent with the findings of Robbins
and Berg for bilateral breast cancer (Robbins et al., 1964). In
life-table analyses and matched comparisons with unilateral
cancer cases, they also found that the second cancer added a
seemingly independent risk. The generally poor prognosis for
women with bilateral cancer diminished when the interval
between the two diagnoses increased. Their conclusions were
drawn, however, from the findings in a hospital-based series.
In three other studies (McRedie et al., 1975; Bailey et al.,
1980; Burns et al., 1984) it has been observed that patients
with synchronous cancers fare badly, while the prognosis for
women with metachronous cancers is better. But in these
studies, metachronous bilateral disease seemed to entail a
prognosis similar to that in unilateral cancer when survival
was calculated from the date of the second diagnosis as in
our study. The discrepancies between our results and those
of the latter studies might have been smaller, however, if
they had taken into account both age and disease stage
(McCredie et al., 1975; Bailey et al., 1980; Burns et al., 1984)
or had used a life-table technique for computing the survival
(McCredie et al., 1975). This assumption is suggested by our
finding that correction for age alone gave less marked
differences between unilateral and bilateral cases. Further-194 L. HOLMBERG et al.
more, age influences survival, the prognosis being better for
women aged 40-49 (Adami et al., 1986; Mueller et al., 1978),
and this age group is more frequently represented among
women with bilateral disease (Mueller & Ames, 1978; Adami
et al., 1985). In another study (Turco et al., 1982) a poorer
prognosis was found for women with bilateral disease, but -
contrary to our results and those mentioned above - patients
with metachronous cancer fared worse than those with
synchronous tumours. The women in that study were referral
patients only and this might have introduced bias.
In four studies (Schell et al., 1982; Slack et al., 1973;
Nielsen et al., 1986; Mueller & Ames, 1978) it was found
that the survival was similar for women with bilateral and
unilateral disease. The study design and analyses differed in
major respects, however, from those of the present investi-
gation, which might explain the contradictory findings. In
two of them only patients with stage I and II disease were
included (Schell et al., 1982; Slack et al., 1973). Furthermore,
one report was based on a hospital series (Schell et al., 1982)
and the other on patients recruited to a randomized trial
(Slack et al., 1973). The report by Nielsen et al. (1986) was
based mainly on autopsy findings on women with clinically
invasive breast cancer prior to death. Mueller and Ames
(1978) compared survival rates without correction for age,
and pointed out that this might have biased the result
towards a more favorable course for the women with
bilateral cancers (Mueller & Ames, 1978; Adami et al., 1986;
Mueller et al., 1978). These particularities in study design
make it difficult to judge the external validity of these
findings vis-ai-vis results for population-based incident cases.
Three further reports (Finney et al., 1972; Harrington,
1953, Lesser et al., 1982) comment upon the prognosis for
women with bilateral cancer. The presentations and statisti-
cal methods do not, however, permit an evaluation of their
external and internal validity and thus make comparisons
with our results impossible.
Thus, the findings in the present investigation are sup-
ported by other evidence in the literature and we agree with
Robbins and Berg (Robbins et al., 1964) that the pattern
observed is plausible from a biological standpoint: The
second cancer adds an additional risk of dying which is close
to two-fold if the cancers are synchronous or occur very near
in time. The risk of dying from the first breast cancer then
declines as the interval between the two tumours increases,
since only women with a reasonably good prognosis live
long enough to experience bilateral disease.
The authors are indebted to Dr A. Rimsten, for valuable assistance
in this research.
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